Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07363525 · ClinicalTrials.gov registry record
Michigan Initial Experience Using Tigertriever for Thrombectomy
A clinical trial, sponsored by Henry Ford Health System.
- Recruiting
- Registry status
- 150
- Enrollment target
NCT07363525 is a clinical trial that is actively recruiting participants, run by Henry Ford Health System. The registered enrollment target is 150 participants.
The verdict
NCT07363525 is actively recruiting participants, sponsored by Henry Ford Health System.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
Study Summary
The purpose of this research study is to collect data about the effectiveness (i.e. how the device works) and safety (how safe it is to use such a device) of the Tigertriever in restoring blood flow by removing thrombus (or blood clot) from a large intracranial vessel (blood vessel in the brain) in patients experiencing ischemic stroke within 8 hours of symptom onset.
Interventions
- PROCEDURE Mechanical Thrombectomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2026-01-15 |
| Est. Completion | 2028-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07363525
The ClinicalTrials.gov registry entry for NCT07363525 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mechanical Thrombectomy is the first listed.
NCT07363525 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07363525 about?
NCT07363525 is a clinical study titled "Michigan Initial Experience Using Tigertriever for Thrombectomy". The purpose of this research study is to collect data about the effectiveness (i.e. how the device works) and safety (how safe it is to use such a device) of the Tigertriever in restoring blood flow by removing thrombus (or blood clot) from a large intracranial vessel (blood vessel in the brain) in ...
What is the current status of trial NCT07363525?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2026-01-15. Estimated completion is 2028-12-31.
What interventions are being tested in trial NCT07363525?
The interventions under investigation include: Mechanical Thrombectomy (PROCEDURE).
Who is sponsoring clinical trial NCT07363525?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.